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Abstract
The microfluidic cell culture enables the study of cell signaling in previously impossible or impractical
ways by allowing the precise spatial and temporal control of the microenvironment to better mimic in
vivo conditions. Microfluidic techniques allow the creation of exact culture geometries, cell patterns,
and the use of perfusion techniques to precisely control external soluble factor signaling and effectively
inhibit autocrine signaling factors. To date, microfluidic techniques have been used to perform single-
cell analyses, generate molecular gradients, and pattern three-dimensional cultures.
The task of identifying and quantifying the cell culture proteome from cell lysate or the secreted
proteins is often performed by the immunoassay. Macroscale immunoassays such as those performed
on the tissue culture plate, however, are of limited use for the microfluidic cell culture due to the limited
volume of sample generated by the microfluidic culture. The ability to precisely patterning cells on the
microscale (10-100um) enables cell study at physiological length scales, but also drastically reduces both
the sample volume and the protein abundance when compared to the tissue culture plate. Due to these
twin challenges of low sample volume and low secreted protein concentration, the detection of protein
antigens by immunoassay on many microfluidic cell cultures applications is currently practically
infeasible.
To address the limitations of low sample volume and low protein concentration, we have developed a
novel microscale immunoassay device capable of the electrokinetic concentration of proteins. This
technique allows us to improve the sensitivity of immunoassays through increasing the antigen
concentration prior to antibody-antigen binding, or preconcentration. Using this scheme, we have
demonstrated a 100 fold sensitivity improvement for antigens directly from cell media without sample
preparation when compared with immunoassays without preconcentration. Our immunoassay also
benefits from sub microliter required sample volume and may be easily integrated directly to
microfluidic cell cultures.
Furthermore, we fabricated microelectrodes integrated on chip to the electrokinetic preconcentrator to
directly measure the electric field which accompanies nonlinear electrokinetic flow. The time response
electrical profiles of electrokinetic preconcentration was obtained and correlated to the protein
concentration profile to study electrokinetic behavior. Our efforts yielded a method to directly visualize
the electric field distribution in nonlinear electrokinetic flow and a direct relationship between the
depletion effects of electrokinetic behavior and the electric field profile.
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Chapter 1: General Immunoassay Principles and Applications to
Biosensing
The immunoassay is one of the most commonly used methods in biology to measure the presence or
concentration of a biomolecule in a simple such as serum or cell culture media. The assay makes use of
the highly specific binding between the antibody and antigen. This provides a method to reproducibly
identify and quantify the presence of antigen if an appropriate antibody can be reliably produced in the
lab.
Antibodies are "Y" shaped soluble protein produced by the immune system of vertebrates and are found
in serum and other bodily fluids. The tips of the Y consist of antigen binding protein fragments (Fab
region). In most cases, the Fab region binds to a specific section or epitope of the appropriate antigen
molecule, analogous to what is usually described as a lock-and-key mechanism. The base of the Y is the
crystallizable fragment (Fc region), whose function is to modulate immune cell activity. Antibodies
protect the organism against foreign invasion through several methods. Antibody binding may interfere
with the function of an antigen protein through steric hindrance, or by inducing conformation change.
The Fc region of a bound antibody also triggers subsequent reactions and immune system cascades to
activate complement defenses or effector cells.
The unique requirements and properties of the antibody mediated immune response make the
antibody-antigen reaction an excellent tool to detect and measure biomolecules in a complex biosample.
Blood serum is a complex mixture of dissolved ions, proteins, sugars, lipids, and other components.
Even within this complex environment, the Fab region is capable of recognizing an essentially unlimited
combination of biomolecules while the constant Fc region allows for chemical attachment to solid
supports and subsequent signal transduction without affecting the antibody's binding affinity.
Antibodies for immunoassays are produced through inoculating an animal with antigens followed by
harvesting of the antibodies from the animal's serum. (1) Antibodies produced this way are called
polyclonal and are antigen specific but are targeted to different epitopes. Monoclonal antibodies, or
those directed against a single epitopes, can be created by isolating and immortalizing a single epitope
targeting B-cell clone.(2) Since polyclonal antibodies target multiple epitopes, polyclonal antibodies are
more robust and resistant to operating conditions such as pH and ionic strength but exhibit greater
batch-to-batch variation, while monoclonal antibodies are in general more specific but less robust.
Enzyme-Linked ImmunoSorbent Assay (ELISA)
The Enzyme-Linked ImmunoSorbent Assay, or ELISA, is the most commonly used immunoassay. The
"sandwich" assay form of ELISA is diagramed in Figure 1. First, capture antibodies are immobilized onto
a solid support, such a polystyrene plate or a microbead. Multiple chemistries are available for this
process, such as nonspecific adsorption, protein A attachment, and streptavidin-biotin interaction. The
immobilized antibody is then incubated with the sample and a secondary antibody. Antigens specific to
the antibodies used will be "sandwiched" between the capture and secondary antibodies. To minimize
the nonspecific absorption of antigens, blocking molecules such as bovine serum albumin or TWEEN 20
are usually added. The secondary antibodies are conjugated to a specially chosen reporter molecule,
such as an enzyme to change color or produce fluorescence. The plate or beads are then washed to
remove excess reagents, and the appropriate enzyme substrate is added. The enzyme substrate
reaction produces a detectable change after multiple reaction cycles. The enzyme substrate reaction
can be quantized and correlated to the concentration of antigen molecules in the original sample.
The secondary antibodies' enzyme label can be easily replaced with other reporter molecules, such as a
chemiluminescent compound, cofactor such as ATP, or electroactive compound. The choice depends
mostly on the sensitivity required and the needs of the application. For ELISAs in the clinical diagnosis
setting, the most common choice is the horseradish peroxidase (HRP) enzyme, which reacts with many
substrates to generate hydrogen peroxide as an oxidizing agent to drive a color change. Figure 2 shows
an example of HRP generated color change in HIV testing.
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Figure 1: Enzyme-Linked ImmunoSorbent Assay (ELISA) for the detection of a specific antigen.
The ELISA benefits from high specificity. This is particularly true in the case of the two-antibody
sandwich assay just described, as each antibody may compensate for any nonspecific binding from the
other one. The primary drawback is the limitation of the antibody-antigen binding kinetics and the mass
transport limitation of the assay. The sensitivity of the microwell plate based ELISA is usually in the
picomolar to nanomolar range, although special amplification techniques can be used to achieve much
femtomolar sensitivities. Most current ELISAs require a minimum sample volume of 50pL.
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Figure 2: HIV testing using ELISA on a 96-well plate. The brown color results from activity by the secondary
antibody's conjugated horseradish peroxidase and indicates the presence of HIV infection in the sample.
The sensitivity of immunoassays is also adversely affected by the amount of background noise. Figure 3
shows the sources of background noise in immunoassays, which includes electronic noise, assay reagent
blank, and non-specific binding. (3) On microfluidic assays, non-specific binding is particularly
problematic due the larger surface area to volume ratio. Most high sensitivity assay designs are created
to reduce one or more of these noises, or to increase the detection signal through various amplification
strategies. For example, the enzyme conjugation in ELISA provides post-binding amplification in the
assay, as each the enzyme bound to each captured antigen reacts with multiple substrate molecules.
Non-specific binding with heterophilic antibodies (directed against proteins from a different species) and
auto-antibodies (such as rheumatoid factor) in blood is a cause of both false positives and false
negatives in immunoassays. (4) The approach to this problem has been the addition of factors such as
animal serum or specific proteins with high antibody affinity to neutralize the interfering antibodies. (5)
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Kinetics of Immunoassays and Limitations
Antibody-antigen reaction kinetics are reversible and governed by the Law of Mass Action. In solution,
the reaction is
[Ag] + [Ab] <4 [AgAb] (1)
where [Ag] is the antigen concentration, [Ab] is the antigen concentration, and [AgAb] is the bound
antibody-antigen complex concentration. By the Law of Mass Action, the rate of accumulation for the
bound complex is given by
d[AgAb] = kf [Ag] [Ab]- kr [AgAb] (2)
dt
where kf is the forward rate, and kr is the reverse rate. The reaction reaches equilibrium when the
forward reaction equals the reverse reaction, and can be found by setting the accumulation rate to zero:
< LIMIT OF DETECTION
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Figure 3: Sources of background noise in immunoassays. (3)
K = k_ [AgAb] (3)
kr [Ag][Ab]
Expectedly, these equations indicate that the accumulation rate is strongly dependent on the antigen
and antibody concentrations. The minimum detectable concentrations or sensitivity of any
immunoassay depends on the concentration of the antibody-antigen complex, and the time required for
detection depends on the rate of reaction. As the antigen concentration drops, so does the equilibrium
complex concentration (equation (1)) and rate of accumulation (equation (2)). Therefore, the detection
of very low concentration antigens is particularly challenging, since the rate of complex accumulation
would be very low and the maximum complex concentration given by the equilibrium reaction may also
be too low to be detected.
Most immunoassays, such as the ELISA, are heterogeneous assays, where the antibody or the antigen
(less frequently) is immobilized onto a solid surface rather than in solution. The equations above are
only approximately correct in these cases because of the presence of a diffusion boundary layer. Shown
in Figure 4, antigens close to the wall react with the immobilized antibodies, resulting in a diffusion layer
near the wall with a lower concentration of antigens than in the bulk solution. The diffusion layer
hinders formation of the bound antigen-antibody complex, since antigens must diffuse across the
boundary to bind with the immobilized antibodies. Convection can reduce the width of the diffusion
layer, but cannot eliminate it because of the no-slip condition at the wall.
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Figure 4: Diffusion layer in heterogeneous immunoassays. Antigens must diffuse across a diffusion layer before
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reacting with antibody. The width of the diffusion layer is higher for lower antigen concentrations.
The time response of a heterogeneous assay with fixed antibodies can be studied by considering
equation (2) with the following convection diffusion equation
a[Ag] + u [Ag] = DV 2[Ag] (4)
at
where u is the velocity vector and D is the antigen's diffusion constant. Nair et. al. (6) estimated the
performance limits of immunoassays based on these equations and arrived at
Nsr (5)
tc< D[Ag]
where tc is the minimum incubation time needed to capture the N, minimum number of molecules
needed to achieve detection, and r is the effective radius of the sensor. Ns is mostly determined by the
immunoassay technology's signal transduction method (optical, impedance change, etc), and r is an
argument for miniaturization of the sensor. For a given incubation time and antigen concentration, the
rate limiting step is the diffusion rate of the antigen rather than the reaction kinetics. (6,7) For this
reason, high sensitivity ELISAs are often incubated for many hours to days. As the antigen concentration
decreases, the incubation time required quickly becomes impractically large. (7-9)
Microfluidic Cell Cultures and Immunoassays
The recent decade has seen the development of the microfluidic cell culture, driven by deficiencies of
the petri dish cell culture. Because the petri disk is inherently a 2D environment, plated cells often form
a monolayer on the bottom of the dish and form morphologies quite different from in vivo tissue
structures. (10) For example, the extracellular matrix in known to affect chromatin structure and
thereby gene expression in mammary epithelial cell lines (11) The dichotomy between 2D and
environment is thought to be due to differences in cell-cell signaling and cell-environment interactions.
In vivo studies on chick embryos show that the fate of individual cells during development do not rely on
just gene expression patterns but take developmental cues from their positions and mechanical forces.
(12) The influence of mechanical forces is also seen in the zebrafish, where large shear forces from blow
flow are needed for proper heart development. (13) The microfluidic cell culture addresses many of the
petri dish's shortcomings. Controlling the flow rate or perfusion sets the desired shear forces and allows
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the separation of autocrine signaling from external signaling by soluble ligands. (14) Furthermore, the
10 to 100m length scale of microfluidic channels approximates physiological cell length scales and
enables the study of precise cell-cell signaling and cell-environment interactions. (15)
Microwell plate based immunoassay such as the ELISA is generally unsuitable for microfluidic cell
cultures. First, the sample volume available is too small for most plate immunoassays. Also, the
microfluidic cultures study a relatively small number of cells under flow perfusion. In contrast, the petri
dish cell cultures study a large number of cells in static media. As a result, higher sensitivity
immunoassays are often required for microfluidic cultures. Furthermore, the autocrine or paracrine
signaling ligands used by cells are usually secreted in tiny quantities. Secretion of TGF-beta by mESCs,
for example, clocks in at ing per 24 hours by 1 million cells. (16). The stringent requirements call for
microfluidic immunoassays to be directly coupled to the cell culture to achieve minimal sample waste
and amplification techniques to achieve high sensitivity.
Current Microfluidic Immunosensing Methods
The current gold standard in microfluidic immunoassays is immunosensing by flow cytometry, mostly
performed by Luminex Corporation. In this technology, microbeads functionalized with capture
antibodies are incubated together with the sample and a secondary labeled antibody in solution. The
beads are then washed and sent through a flow cytometer. Inside the instrument, hydrodynamic
focusing passes single beads through a section of the channel undergoing laser excitation, causing the
bead and secondary antibody label to fluoresce. A fluorescence detector reads the emitted
fluorescence to determine whether antigens are captured on the bead and thus present in the original
sample. (17) By varying the composition of the bead, label of the secondary antibody, and using multi-
wavelength lasers and detectors, immunosensing by flow cytometry can be used to simultaneously
quantify up to 100 antigens with a detection sensitivity as low as 1pg/ml. (Luminex xMap Platform, (18))
Imunosensing by flow cytometry has inherent multiplexing power, since the only challenge between
implementing the assay to detect one antigen and multiple antigens is in engineering the labels and
optics. Furthermore, the antibodies can easily be readily by other molecules, such as oligonucleotides
and lipid receptors. As a result, it is often used to obtain protein expression profiles or genotype single
nucleotide polymorphism. (19) The primary disadvantage is that the incubation step requires a 40iL
sample volume, beyond the range of many microfluidic studies. Direct integration of cell cultures to the
technology is also mostly impractical, since the expensive and bulky flow cytometer is usually accessible
only as an off-site service rather than in-house technology in most research labs.
Beads with Laser excitation
antibodies & antigen
flow direction ' :
Figure 5: Diagram of microfluidic immunosensing by flow cytometry. Beads functionalized with capture
antibodies are incubated with the sample and label secondary antibodies. These beads are then fed into a
cytometer and interrogated with laser excitation. Multiplexing is achieved through using multiple bead
compositions, antibodies labels, and multiple wavelength lasers.
Sensitivity Improvement by Post-binding Amplification
Postbinding amplification increases the signal to noise ratio of the immunoassay through chemical or
biological techniques performed after the antibody-antigen reaction. The most common technique,
presented in an earlier section, is the use of an enzyme labeled secondary antibody which reacts with
multiple substrate molecules for each binding event. Extending this technique to multiple steps leads to
additional amplification, where the first enzyme-substrate reaction produces a product which amplifies
a subsequent detection reaction. Using this method, a 100-fold improvement in sensitivity has been
demonstrated. (20) The technique of using multiple enzyme amplification steps has been used to
quantify extremely low protein concentrations. For example, the acetate kinase enzyme has been used
to convert ADP to ATP to drive the fire fly's luciferin protein into fluorescing and quantify acetate kinase
in the zeptomolar concentration range. (21)
The most impressive post binding amplification techniques developed to date is amplification by PCR,
where the antibody-antigen reaction leads to the release of short reporter DNA sequences which can be
amplified through PCR. Figure 6 diagrams the use of a liposome/DNA mediated immunoassay. Samples
urine containing CTBS and liposomes functionalized with a lipid receptor specific to CTBS is incubated
- -C IL~ C- -I r 31 ------~--
over a glass slide functionalized with CTBS capture antibodies. After washing the slide, DNAse is added
to remove any nonspecifically bound DNA present in the sample and then denatured by heating the
slide. The reporter DNA encapsulated inside the liposome is then released by chemically degrading the
liposome membrane, followed by quantification of the reporter DNA by real time polymerase chain
reaction (PCR). The achieved sensitivity was 0.75fg/ml (377 molecules) in farm runoff samples and
0.09fg/ml (43 molecules) in urine samples. In this case, cholera toxin beta subunit (CTBS) is the antigen
under assay, although the technique can be readily adapted to a general immunoassay. (22)
1. Antibody to CTBS
4. DNAse addition
2. CTBS binding
5. Denature DNase I
800C
3. Liposome binding
6. Triton X-100
Figure 6: Diagram of liposome-PCR immunoassay to quantify cholera toxin beta subunit (CTBS). 1-3. The CTBS
toxin is sandwiched between anti-CTBS and a liposome containing reporter DNA. 4-5. DNAse is added to
destroy any stray DNA in the sample. 6. The surfactant Triton X-100 is added to degrade the liposome
membrane, and real time PCR is used to quantify the reporter DNA released. (22)
Nam et. al. devised a similar sandwich assay with a nanoparticle probe. Microbeads functionalized with
capture antibody and nanoparticles functionalized with both the secondary antibody and reporter DNA
sequences are incubated with the sample, resulting in microbead-antigen-nanoparticle complexes.
After washing to remove unbound nanoparticles, the reporter DNA sequences on the bound
- PCR
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nanoparticles are be released and identified with PCR. The sensitivity after PCR is 3 attomolars, and
multiplexing can be achieved easily by using beads functionalized with different antibodies and DNA
segments. (23)
Despite very impressive sensitivities, PCR strategies have largely not been miniaturized successfully to
microfluidic formats, mostly since microfluidic PCR is not yet reliable.
Sensitivity Improvement by Sensor Miniaturization and Improved Signal
Transduction
The sensitivity can also be improved by novel signal transduction capabilities. Kurita et. al. created a
two stage competitive microfluidic immunoassay based on surface plasmon resonance (SPR). The
biological sample is first reacted with an enzyme conjugated antibody in known excess concentration.
The remaining unbound antibody is reacted with the substrate. The enzyme reaction produces a thiol
product that binds to a gold surface downstream, resulting in an angle change in the SPR output signal.
Picomolar sensitivity was achieved, but a potential drawback is the difficulty in selecting a proper excess
antibody concentration if the antigen order of magnitude is unknown. SPR is the current gold standard
for determining binding kinetics and is being developed in the microfluidic form. (24)
In microcantilevers designs, antigen binding to an antibody functionalized cantilever changes the
cantilever's deflection or resonant frequency. (25) (26) Femtomolar sensitivity can be achieved. Unlike
most immunoassays, microcantilevers assays do not require optical detection but need sensitive
electronics. Smaller devices lead to higher sensitivity since the relative impact of a single binding event
increases as the sensor size decreases. The current limit for this miniaturization process is the nanowire
sensor, where silicon nanowire transistors are modified into immunoassays through the chemical
attachment of capture antibodies. (27) The nanowire conductance changes upon antigen binding, with
reported detection sensitivity range also in the femtomolars. Multiplexing capability was achieved
through the attachment of multiple antibodies to multiple nanowires.
Chapter 2: Sensitivity Improvement through Prebinding Concentration
Post-binding amplification strategies can lead to very impressive detection sensitivities. In general,
posting binding amplification seeks to achieve high sensitivity by amplifying a small number of antibody-
antigen binding events. These strategies, however, cannot address the diffusion limited nature of mass
transport in high sensitivity immunoassays. Figure 7 illustrates this diffusion limited nature by showing
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the binding dynamics of R-Phycoerythrin (RPe) obtained using a bead based microfluidic immunoassay.
Microbeads were functionalized with anti-RPe antibodies, immobilized inside a microfluidic channel, and
incubated with the sample under a high flow rate (>lmm/s, lCpl/min). (The experimental setup is
presented in more details in the next chapter.) At RPe concentrations above Cpg/ml, equilibrium was
rapidly achieved within 10 minutes. However, at lower concentrations, equilibrium was not achieved
during the 60 minute experiment. These results indicate that in spite of the high convection rate, the
antibody-antigen binding kinetics results in a diffusion limit mass transport regime for immunoassays
detecting a sample concentration of RPe less than 1lg/ml. Figure 7 also clearly shows that increasing
the incubation time from 30 minutes to 60 minutes only marginally improved the detection result,
despite consuming an additional 30pl of sample.
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Figure 7: Microfluidic immunoassay without preconcentration performed inside the immunoassay without
prebinding amplification. Microbeads were functionalized with anti-RPe antibodies and incubated with N2B27
media spiked with RPe under a 1mm/s perfusion rate inside the microfluidic channel. The intensity of the bead
correlates to the amount of RPe captured. A: At the RPe concentration decreases below 100ng/ml, the rate of
RPe binding decreases significantly due to the limitations of antibody-antigen binding kinetics. B: Increasing the
incubation time from 30 minutes to 60 minutes only marginally improved immunoassay performance,
suggesting longer incubation will not lead to significant increase in sensitivity.
Wang et. al. demonstrated an prebinding amplification strategy for immunoassays to detect RPe by
electrokinetically preconcentrating the antigen molecules and achieved a 1000 fold sensitivity
improvement. (28) Unlike post amplification where the strategy is to maximize the signal from each
binding event, prebinding amplification seeks to increase the number of binding events by increasing
the concentration of antigen molecules near the capture antibody. The higher antigen concentration
shifts the immunoassay into more favorable binding dynamics, with a higher equilibrium binding
concentration and lower incubation time.
A variety of techniques have been developed to increase the local concentration of antigens. Solid
phase extraction uses affinity, electrostatic, or other nonspecific forces to bind analyte to a solid surface,
followed by the introduction of a second buffer to elute the concentrated samples. The maximum
concentration factor is approximately 1000. (29) Isoelectric focusing (IEF) is primarily a method to
separate proteins by their pl value, or isoelectric point. (30) Sample proteins in a channel
electrophoretically migrate down a pH gradient and pile up at the pH value equal to its pl. Field
amplified sample stacking (31) and isotachophoresis (32) creates two or more regions of differing
conductivities. Since the flow speed of charged analytes depends on the electric field strength, changes
in electric field strength at the region interfaces creates analytes flow "bottlenecks" and concentration
plugs. Furthermore, the locations of these concentration plugs depend on the electrophoretic mobility
of the ion in question, allowing the separation of ions by mobility. All these techniques, however,
require the use of special buffers, limiting their integration capability.
Preconcentration using Electrokinetic Trapping
Electrokinetic trapping's principle of operation is based on the depletion and enrichment effects which
accompany charge selective transport. The electrolyte concentration profile near a (cation) charge
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selective membrane is shown in Figure 8. Under an applied electric field, (positive) counter ions are
preferentially transported across the membrane. According to classical concentration polarization
theory, (negative) co-ions will be repelled from the membrane's anode side to maintain
electroneutrality, leading to a drop in electrolyte concentration (C1 in Figure 8). On the membrane's
cathode side, (negative) co-ions are attracted to neutralize the excess (positive) counter-ions
transported their through the membrane, leading to enrichment of the electrolyte concentration (C2 in
Figure 8). Equilibrium is reached when the ion drift fluxes is equal to the diffusion fluxes on both sides
of the membrane. 6 is the diffusion layer distance, and is dependent on the bulk electrolyte
concentration, applied field strength, and convection velocity.
Under higher applied electric fields, classical concentration polarization theory must be modified by
considering both fluid flow and concentration development to accurately predict experimental results.
(33) Solving standard drift-diffusion equation under the condition of strong concentration polarization
was shown to lead to a mathematical solution that predicts a space charge region, but it is also
important to analyze fluid flow of the system (in addition to diffusion and drift) in order to properly
understand the system. In fact, it was theoretically predicted and experimentally shown that a strong,
convective flow would exist near the perm-selective nanochannel, which then destroys the
concentration gradient (depletion). (34) Due to the coupled nature of this problem, correct modeling of
this phenomenon is still challenging and requires substantial scientific studies. The exact fluidic
properties and behavior of the ion depletion region are not entirely understood and out of the scope of
this thesis. Interested readers are referred to much more detailed discussions in (33).
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Figure 8: Left: Electrolyte concentration profiles near a charged selective membrane as predicted by classical
concentration polarization theory. Right: A large applied electric field induces nonequilibrium convective flow
and concentration gradient due to charge selective transport across the membrane.
The mechanism for preconcentration is conceptualized in Figure 9 in a microfluidic format. As drawn in
the figure, the device consists of a 20-100pm microchannel connected to other microchannels (not
shown) via charge selective membranes. When an electric field is applied through the membrane,
counter-ions are removed preferentially from the microchannel through the membrane, and co-ions are
repulsed from the region to maintain electroneutrality. An induced ion depletion layer forms outside of
the membrane and expands to span the microchannel. This forms a region largely depleted of ions
named the depletion zone. Electroosmotic or pressure driven flow is then used to bring in additional
charged species, which largely do not cross into the depletion zone and therefore stack up and
concentrate at the depletion zone boundary.
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Figure 9: Mechanism of electrokinetic trap development and preconcentration in microfluidic device. A: Applied
electric field leads to preferential transport of counter ions through the membrane and repulsion of co-ions to
maintain electroneutrality. B: Induced space charge layer (depletion zone) largely free of ions. C: Additional
charged molecules brought in by fluid flow stack and concentrate at the depletion zone boundary.
Several micro/nanofluidic device designs take advantage of this preconcentration mechanism by
induced space charge layer generation. Wang et.al micromachined a silicon/oxide preconcentration
device capable of up to a million times increase in concentration in 1mM phosphate buffer at pH9 in
less than one hour of operation. (35) (28)
Lee et. al. created a polydimethylsiloxane (PDMS) device using a micro-patterned charge selective
polymer as the charge selective membrane.(36) As shown in Figure 11, the demonstrated
preconcentration factor was up to 104 in 5 minutes for 13- Phycoerythrin protein in 10mM pH7 sodium
phosphate buffer. The preconcentration performance was similar to the silicon/oxide design with much
simpler fabrication steps, but repeatability suffered somewhat due to the less precise membrane
micropatterning process.
Despite very impressive preconcentration performance, the primary of drawback of both designs is
electrokinetic instability when operating in higher ionic strength buffers such as cell culture media or
blood serum. The instability often prevents the formation of a stable depletion zone. In this thesis, an
immunoassay device is presented based on an improvement of the PDMS design capable of operating in
cell culture media.
EFigure adapted from (35) (28)
Figure 10: Performance and schematic of silicon/oxdie micromachined device. The charge selective membrane
is created by reactive ion etching at array of 4Onm nanochannels. A/B/C: Fluorescent images taken during the
preconcentration of 33fM green fluorescent protein (GFP) in 10mM phosphate buffer. D/E: Fluorescent
intensity increase in the concentration zone during preconcentration of GFP at various starting concentrations.
Up to 106 fold concentration increase can be achieved.
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Figure adapted from (36)
Figure 11: Microfluidic preconcentration device fabricated in PDMS with micro-patterned NafionO polymer as a
cation selective membrane. A: Image of the device. B: Operating schematic. C: Preconcentration of B-
Phycoerythrin protein in 10mM pH7 sodium phosphate buffer versus electrokinetic trapping time.
Chapter 3: Preconcentration and Immunoassay by Polymer Soft
Lithography
Application to Microfluidic Cell Culture Assay and Benefits over Existing
Techniques
In this thesis, a novel immunoassay device is presented consisting of integrating a PDMS
preconcentrator design with a bead based immunoassay. The integrated immunoassay device can
solve the low sample volume problem through direct on-chip coupling to microfluidic cell cultures.
Figure 12 diagrams the device's operation principle. PDMS pillar structures are fabricated near the
charge selective membrane and used to immobilize antibody functionalized microbeads. Under
electrokinetic operation, the concentration zone develops near the microbeads, where the charged
antigen molecules collect increase in concentration. When operating with N2B27 cell media, a 200 fold
MEMIK
increase in antigen concentration can be achieved in 30 minutes. The higher antigen concentration near
the beads facilitates binding and results in a more sensitive immunoassay.
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Figure 12: A) Diagram of electrokinetically preconcentrated immunoassay. The conduction of ions through the
charge selective membrane leads to formation of the electrokinetic trap. Charged antigen molecules
(diamonds) brought in through fluid flow cannot flow past the trap boundary. The increased antigen
concentration in this concentration zone favors increased antigen-antibody binding. B) Fluorescent image of R-
Phycoerythrin the concentration zone.
The bead based immunoassay device design decouples the microfluidic device design from the antibody
immobilization chemistry. The functional attachment of antibodies to microbeads is a well defined,
reliable commercial process which occurs outside of the device. When combined with electrokinetic
preconcentration, the device enables highly sensitive, multiplexed, and microliter volume antigen
concentration measurement which may be performed in near real time requiring only the replacement
of beads. Unlike sensor miniaturization or novel transduction strategies which require complicated
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clean room fabrication or delicate electronics, the device requires only a single lithography mask with
511m resolution and can be operated with a simple fluorescent microscope.
Device Design and Fabrication
Microchannel Fabrication
Fabrication for the device is divided into two processes. The first occurs in the clean room to create a
silicon master for the device microchannels, and the second is the polymer patterning process which can
be performed outside of the clean room. We fabricate the PDMS structure containing microchannels by
soft polymer lithography. (Figure 13). First, we create a photomask by printing the microchannel design
onto a glass plate (Fineline Imaging, Colorado Springs, CO). Contact lithography (EV1, Electronic Vision
Systems, AZ) with this mask was used to pattern thin photoresist (~"l1m height) on a 6in silicon wafer,
followed by deep reactive ion etching (DRIE, Surface Technology Systems, United Kingdom) using SF6
etchant and C4F8 passivation (Bosch process) to a depth of 10 microns. The relatively large 51Lm feature
size and uniform 10lOm required etch depth leads to a relatively simple fabrication process, as only a
single mask is needed and the DRIE to 101m is easily achieved without complicated recipes. After
stripping the photoresist using oxygen plasma, a perfluorinated trichlorosilane (T2492-kg, United
Chemical Technologies, Bristol, PA) is evaporated next to the silicon master inside a vaccum chamber to
deposit silane onto the wafer and cover the exposed silicon surface. We then mix PDMS prepolymer
and curing agent (Dow Corning Sylgard 184 Silicone Elastomer Kit) in a 10:1 ratio. After degassing in a
vacuum chamber, we pour the PDMS liquid mixture onto the silicon master and cure the polymer at
1200C for 15 minutes. The cured PDMS does not bond to the silane coated surface and can be peeled
off the mold and cut to individual dies. We then drill 1mm diameter holes vertically into the PDMS to
create the fluid connections to the microchannels.
S3.Expose through photomask1.Blank silicon wafer 2.Coat photoresist
4.Develope photoresist 5. Remove photoresist 6. Cast and cure 
PDMS polymer
7. Remove PDMS from mold 8. Cut and drill fluidic connections
Figure 13: Device microchannel fabrication steps. 1. Silicon wafer. 2. spin coat photoresist to a height of 1pm. 3.
Expose to UV with photomask to define microchannel pattern. Photoresist not covered with mask features
become soluble to the developer. 4. Deep reactive ion etching with SFJC 4Fs Bosch process etches silicon from the
wafer in areas not protected by photoresist to 10pm. 5. Plasma ashing with oxygen gas to remove photoresist.
The result is a mold of the microchannel features in monolithic silicon.
We then create the nanochannel structures needed to bridge the device's main and side channels, as
shown in Figure 14. Clean glass microscope slides are baked at 200*C for approximately 15 minutes for
dehydration and to ensure a hydrophilic surface. A PDMS chip containing a single 1cm long, 100Pm
wide, and 50pm high microchannel is reversibly bonded to the glass slide. We place a small drop of
Nafion" perfluorinated resin solution (product number 527122, Sigma-Aldrich, St Louis, MO) in one
reservoir and apply negative pressure at the other reservoir. When the channel is filled with the resin
solution, we peel off the PDMS and place the glass slide on a 950 C hotplate for approximately 10
minutes to cure the resin. Finally, the PDMS microchannels and glass slide is treated with oxygen
plasma and irreversibly bonded. Alignment of the microchannel features and Nafion® resin pattern is
performed using a stereomicroscope. The flexible PDMS is capable of sealing around the cured resin
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without visible fluid leakage during the experiment. Since the Nafion® resin contains 80% solvent, the
height of the membrane is much less than the channel depth. Therefore, fluid flow through the
channels is not impeded by the membrane. The finished device is then baked on a 95°C hotplate
overnight to improve bonding, and then stored under vacuum. Vacuum storage removes air from PDMS
and minimizes the appearance of air bubbles when the device is used.
Figure 14: Device nanochannel patterning bonding. 1. Plain microscope slide. 2. Reversible bonding of PDMS
chip with patterning channel. The patterning channel is filled with Nafion* prepolymer. 3. The PDMS patterning
chip is removed, and the Nafion resin solidifies following 95C bake for 5 minutes. 4. The PDMS chip containing
the device microchannels and glass slide is exposed to oxygen plasma and irreversibly bonded.
A top down schematic and bright field image of the device is shown in Figure 15. The device consists of
a main channel (reservoirs Vc and Vm) surrounded by a side channel (reservoirs Vs). The mechanism of
operation will be described in a later section.
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Figure 15: Top down schematic of the immunoassay device. A: The device consists of one main channel
(reservoirs V and Vm) and one side channel (reservoirs V,). The two channels are connected near the bead traps
by the Nafion* charge selective membrane. B: Bright field image of the device near the Nafion* membrane. m:
main channel, s: side channel, t: bead trap features, n: Nafion* membrane. The height of the membrane is
significantly less than the channel depth and does not impede fluid flow.
Bead Functionalization and Immobilization
FMAT ® streptavidin functionalized 6-8pm polystyrene beads (0.5%w/v, Applied Biosystems) were used
as solid support for the device's capture antibodies. A mixture of 320pL of beads, 800pL of IX PBS at pH
7.4, and 2pg of biotin conjugated anti-R-Phycoerythrin (RPe) were incubated in a centrifuge tube for 8
hours. The mixture is then centrifuged to remove the supernatant several times followed by
resuspension of the beads in 1X PBS with 1% bovine serum albumin (BSA). Removing the supernatant
washes away excess unbound antibodies and the BSA reduces nonspecific binding inside the mixture.
This process of bead functionalization is a well established commercial process and very repeatable so
long as there is an excess of antibody to streptavidin binding sites. Functionalization processes which
happen outside of the microdevice are preferable since they decouple the device design from the need
to consider complicated surface chemistries which often need to be tailored to each antibody or other
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molecule. We have chosen to attach antibodies for our immunoassay device, but other biomolecules
such as enzymes and DNA probes may be similarly attached by the same streptavidin-biotin interaction
and used in our device without modification. Furthermore, the use of beads as mobile solid supports
allows us to control the movement of functionalized antibodies in the device. The enables longitudinal
immunoassay studies in the same device simply by replacing the beads when needed.
Bead immobilization is shown in Figure 16. This process is adapted from the technique developed by Di
Carlo et. al. (37) The bead traps are PDMS features in the main channel. When a bead trap is empty,
the fluidic resistance through the trap is approximately equal to the resistance of the flow paths around
the trap. When a bead fills and blocks the trap, the fluidic resistance becomes much larger and the
resulting fluid flow diverts other beads to other traps further downstream. This immobilization method
mostly leads to one immobilized bead per trap with fairly good repeatable results. Furthermore, the
simple pillar features needed to fabricate the traps are uniform in height with the channel wall, thus
allowing single mask fabrication. The main drawbacks are in difficulties removing the bead from the
device once trapped and the constant need to maintain the pressure gradient to keep the beads from
diffusing away.
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Figure 16: Immobilization of antibody-labeled microbeads in the main channel adapted from (37). The
technique's main principle is fluidic resistance modulation. When a bead fills the trap, the fluid path through
the trap is blocked and subsequent beads flowing in are directed towards other traps downstream.
Immunoassay without Preconcentration
Baseline immunoassay results were obtained using the device without preconcentration. Following
immobilization of anti-RPe functionalized beads in the main channel, a syringe pump was used to
incubate the beads in N2B27 stem cell media with various concentrations of RPe added. The fluorescent
RPe molecule causes the anti-RPe functionalized beads to fluoresce when captured by the antibody.
Fluorescent imaging was performed using an inverted epi-fluorescence microscope (IX-71, Olympus,
Melville, NY) with a thermoelectrically cooled CCD camera (Sensicam QE, Cooke Co., Auburn Hills, MI)
and a 100W mercury lamp (Chu Technical Corp., Kings Park, NY). The RPe fluorescence was visualized
using a TRITC filter set (excitation 562nm, emission 624nm, Semrock, Rochester, NY). Exposure time
was precisely controlled through a programmable mechanical shutter to minimize sample
photobleaching. Images were analyzed using the IPLab imaging processing software (IPLab 3.5,
Scanalytics, BD Bioscience, Rockville, MD).
Immunoassay results for the detection of RPe without preconcentration is shown in Figure 7.
Equilibrium antigen-antibody binding have been reached for incubation with RPe concentrations above
lpg/ml (>lmm/s), where the intensity versus time curve approaches the equilibrium value exponentially.
At lower concentrations, the binding response becomes roughly linear, and the equilibrium value is not
reached within the one hour experiment. Figure 7B compares the 30 minute incubation result to the 60
minute experiment. Despite doubling the incubation time, the detected intensity only increased
marginally, suggesting that increasing the incubation time is an inadequate way to improve
immunoassay performance.
Immunoassay with Preconcentration
The operating parameters for preconcentration are shown in Figure 17. Pipette tips are inserted into
the fluid connections of the device and act as fluidic reservoirs. The outer side channel is filled with 1X
PBS, with pressure balanced at the reservoirs V, by filling the pipette tips to an equal level. The main
channel reservoirs are filled with the sample under detection and the reservoir relative levels (channel
pressure) are optimized for stability and speed of preconcentration. We used IX PBS (P3813, Sigma-
Aldrich, St Louis, MO, NaCI 0.138 M; KCI 0.0027 M) or N2B27 media with lpg/ml green fluorescent
protein (GFP, "28kDa, pl=6) and the varying concentrations of R-Phycoerythrin (RPe, "270kDa, pl=4.5).
GFP is used as a fluorescent tracer to allow us to set the correct flow conditions and voltages for each
experiment, and RPe is the protein under detection and targeted by the capture antibodies. Control
experiment were performed to no cross reactivity between anti-RPe and GFP.
The applied electric field across the Nafion® membrane is set by modulating the voltages at the Vs and
Vm reservoirs. The voltages are set by placing platinum wires into the reservoirs and connecting them to
a power supply. Generally, Vs is grounded and Vm is dynamically changed to optimize for stable
depletion and concentration zones. Both the main channel pressure and Vm voltage are strongly
dependent on the buffer or media in the main channel. When the proper pressures and voltages are set
and depletion zones balanced, electrokinetic preconcentration proceeds, and proteins (and other
charged molecules) stack up inside the concentration zone.
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Figure 17: Diagram of preconcentration device operation. The center channel is filled with the sample in cell
culture media media or PBS and the side channel is filled with PBS buffer. Positive pressure driven flow is set by
controlling the liquid column heights between the Vm and V, reservoirs. When appropriate voltages are set as
indicated and Vm is dynamically determined, electrokinetic preconcentration proceeds and antigen accumulate
in the concentration zone.
The preconcentration of 1pg/ml RPe in N2B27 media is shown in Figure 18. The preconcentration factor
in this case is approximately 200 over 30 minutes.
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Figure 18: Preconcentration of 1g/ml RPe in N2B27 media using immunoassay device. A: Fluorescence image
of the concentration zone at various times. B: average fluorescence values of the concentration zone versus
time. The preconcentration factor is 200 over 30 minutes.
The impact of preconcentration on the RPe concentration distribution is shown in Figure 19, where the
preconcentrated immunoassay was performed for ing/mi RPe in N2B27 media. The beads in the
concentration zone near the Nafion membrane captured the most RPe molecules and had the highest
fluorescent intensity. Upstream of the concentration zone, the beads were less flourescent as these
beads encountered RPe at the base concentration of ing/ml. The downstream beads are extremely
faint and almost not visible. This is because only a small amount of RPe escaped downstream from the
concentration zone and across the electrokinetic depletion boundary. Figure 20 shows similar results in
a comparison of bead intensities upstream, downstream, and at the Nafion membrane over many
experiments and at several RPe concentrations.
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Figure 19: Fluorescent image showing captured RPe molecules on anti-RPe functionalized beads after 30min
preconcentration of Ing/ml RPe in N2B27 media. Due to preconcentration, the intensity of beads in the
concentration zones is higher than those in the unconcentrated zone upstream. Only a small amount RPe
escapes the concentration zone and flows downstream, as evidenced by the very faint intensity of the
downstream beads.
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Figure 20: Comparison of fluorescence intensity among beads upstream, inside, and downstream of the
concentration zone after 30min preconcentrated immunoassay of RPe in N2B27 media.
The results of 30min preconcentrated immunoassays for various concentrations of RPe in N2B27 media
are compared to the incubation only immunoassays in Figure 21. At each concentration of RPe, the
preconcentrated immunoassay resulted in higher antibody-antigen binding, as evidenced by the
increased fluorescent intensity from captured RPe on the microbeads. The sensitivity for RPe without
preconcentration using our experimental setup is Ing/mi while consuming 30-601l of sample.
Preconcentration improved the detection sensitivity by 100 fold to 10pg/ml. The sample consumed
during preconcentration was measured to be less than 1il based on measuring the level of sample
remaining in the inlet reservoir.
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Figure 21: Immunoassay to detect RPe in N2B27 media with 30 minute preconcentration. Preconcentration
improved detection performance by approximately 2 orders of magnitude. All assays were performed using the
same optics setup and exposure settings.
In Figure 22, the function of the preconcentrated immunoassay device was extended to detect the non-
fluorescent antigen C-Reactive Protein (CRP). Preconcentration of CRP in N2B27 stem cell media was
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performed near anti-CRP functionalized beads, followed by flowing in 10lg/ml FITC-anti-CRP as a
detection antibody. Both the incubation and preconcentration curve was obtained using a flow rate of
less than 1IL a minute, to approximate the amount of sample available for microfluidic cell cultures.
The demonstrated signal enhancement was 10 fold.
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Figure 22: A. Immunoassay to detect RPe in N2B27 media with 30 minute preconcentration. B. Fluorescence of
FITC-anti-CRP after Ing/mi CRP preconcentrated assay. The higher concentration of CRP in the preconcentration
zone (right of Nafion) results in greater capture of CRP and higher fluorescence.
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Discussion and Significance of Results
The novel PDMS microfluidic immunoassay device described in this thesis is the first to successfully
demonstrated detection of a nonfluorescent protein antigen directly from cell culture media. We have
demonstrated an a reduction in the detection limit of RPe by two orders of magnitude and
demonstrated the improved detection of CRP by sandwich immunoassay based on the principle of
electrokinetic pre-binding amplification. Importantly, the detection was conducted directly from N2B27
cell culture media and consumed less than 1pL of sample. The use of prebinding amplification to
achieve higher immunoassay sensitivity while consuming lower amounts of sample potentially allows
the preconcentrated immunoassay device to achieve direct detection of low abundance antigens from
microfluidic cell cultures. Furthermore, since electrokinetic preconcentration is used to improve binding
dynamics before use of the secondary antibody, the device can be engineered readily to include
postbinding amplification to achieve higher sensing performance.
Electrical Profile Measurement near the Charge Selective Membrane
Electrokinetic trapping's principle of operation is based on the depletion and enrichment effects which
accompany charge selective transport. Since the ion concentration near the charge selective membrane
is depleted, the potential drop across the entire microchannel becomes focused on the depletion zone.
Furthermore, the lower ionic strength results in an effectively lower zeta potential. These two effects
combine to create an amplified electrokinetic response characterized by fast following rotating vortices.
(38)The electrical field distribution which drives this electrokinetic response, however, has never been
measured. In this section, we describe the results of electrical field measurements conducted near the
Nafion membrane in a PDMS preconcentration device.
Figure 23 shows the microfluidic preconcentrator design used for the electrical measurements, where
integrated microelectrodes are fabricated on the glass cover of the device to provide electrical access to
the microchannels. The fabrication of the electrodes proceeds as follows. First, standard
photolithography is used to pattern NR7 photoresist to a thickness of 3pm onto a pyrex wafer. We then
expose the wafer to UV through a mask rendering the electrode pattern soluble to the developer.
Following development, a layer of 10nm titanium followed 90nm of gold is deposited over the wafer
using electron beam deposition (Temescal Semiconductor Products). The wafer is then incubated in
acetone to dissolve all exposed photoresist areas and lifts off the deposited metals except at the
electrode pattern. The wafer is then diesawed and fabrication then proceeds with membrane
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patterning and bonding to the PDMS microchannels structure as described in the previous chapter. The
PDMS microchannels structure is bonded with the microelectrodes open to the main microchannel near
the Nafion membrane. The PDMS structure covers only half of length of the electrodes, allowing wires
to be soldered onto the exposed portion.
electrodes
Figure 23: PDMS preconcentrator with integrated electrodes for electric field measurement near the charge
selective membrane.
During device operation, all the pressures at the four reservoirs are balanced. All channels are filled
with 10mM sodium phosphate buffer at pH 9 and 10nM fluorescein isothiocyanate (FITC). Electrical
input to the preconcentrator is provided by inserting platinum wires into the reservoirs. The reservoirs
at Vs are electrically grounded and the voltages at Vm and Vc are chosen dynamically to stabilize the
concentration and depletion zones. This scheme is slightly different from the one used in the
immunoassay, which utilizes a pressure driven flow to establish the concentration zone. The voltages
between microelectrodes are sampled using a Keithley 236 current/voltage source-measure unit
(Keithley Instruments, Inc.) whose high input impedance (200TO) will ensure minimal interference with
the depletion and concentration processes. The size and profile of the concentration and depletion
zones near the membrane is indicated by the brightness of the FITC dye. We then correlate these
profiles to the electrical profile measured on the microelectrodes to study the preconcentrator's
electrokinetic behavior.
_
A typical time response of the electric field strength after voltage is applied is shown in Figure 24, where
the operating voltages are V,=50V, Vm=20V, and Vs=OV. In the device measured, the Nafion membrane
is patterned between the v5 and v6 electrodes. During preconcentration, the depletion region partially
covers the region between v3 and v4 and the entire region near v4 and vs. As preconcentration starts,
the charge selective transport of ions through the membrane leads to an amplified electric field in the
lower ionic strength depletion region. The depletion region is then seen expanding away from the
membrane, corresponding to the increase in electric field strength between v3 and v4 . For the most part,
v12 and v23 remains constant near 60V/cm. This is because the depletion and concentration zones do not
include the space between v, and v3 for the duration of the experiment. There was nearly linear voltage
drop from the reservoir to the concentration zone, a distance of 0.5cm (30V/0.5cm=60V/cm). These
results are in compliance with recent one-dimensional modeling studies. (39,40) The potential drop
from vs to v6 is initially negative and gradually increases. A nonzero voltage voltage between vs and v6 is
seen even when the operation voltage is not set. This is because the channels are flushed with
electroosmotic flow which interacts with the Nafion membrane to generate depletion and enrichment
effects even without electrically connecting the side channels. The measurement results across multiple
experiments tend to create variable profiles of vs56 depending on the initial statement from
electroosmosis as well as the charge profile of the side channel and membrane. The presence of a
negative voltage drop from v5 to v6 is seen stably across many experiments and indicates the direction
the electroosmotic flow in the device is towards the membrane from both sides of the channel. The
flow direction however, is left to right due to the much greater amplified electrokinetic response in the
depletion zone.
These integrated microfluidic electrodes are the first time direct, spatially resolved voltage
measurements are made for microfluidic electrokinetic preconcentration and provides an electrical
profile for the study of electrokinetic preconcentration behavior. From the practical standpoint,
correlation of this electrical profile to the location of the depletion region may allow us to track the
concentration zone and set the electrical and pressure operating parameters without the need for a
fluorescent tracer.
Electric Field Measurement Near Depletion Region
Future Work
Continued development of the preconcentrated immunoassay may be directed towards integration with
novel microfluidic cell culture experiments. As microfluidic cell cultures can better mimic in vivo
microenvironments through precise control of perfusion conditions and culture geometry, the
integration of the preconcentrated immunoassay with microfluidic cell cultures will lead to an important
new tool to study cell biology. Specifically, the next steps in the development of this immunoassay are:
1. Miniaturization of the preconcentrator by one order of magnitude to a main channel cross
section of 10pm by 1pm. The electrokinetic trapping effect of the preconcentrator depends on
the formation of the ion depletion region in the microchannel, which is an extension of the
electrical double layer in the charge selective membrane. The high ionic strength of the cell
media decreases the electrical double layer width decreases, thus weakening the SCL. While we
have demonstrated the operation of preconcentrated immunoassay in cell media, the device
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Figure 24: Electric field strength near the Nafion membrane as measured by integrated microelectrodes. The
lower ionic strength in the depletion region results in an amplified electric field.
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requires a more stable operation profile to be useful as a quantitative tool. Decreasing the
dimensions of the microchannel compensates for the weakening depletion forces.
2. Due to the reduced channel dimensions, an alternative to the bead based solid support may be
needed. The most promising is patterning the antibody directly to the glass slide of the device.
Several surface chemistries are available, but the most straightforward technique is the use of a
patterning channel (similar to the Nafion ® membrane patterning channel used currently) to
nonspecifically absorb a streptavidin pattern onto the glass slide. Biotin conjugated antibodies
can then be spotted onto the streptavidin to bind capture antibodies in the correct capture
orientation.
3. Fluorescent tracer characterization. For preconcentrated immunoassays, a fluorescent tracer is
needed to dynamically set the correct operating pressures and voltages. Proteins of different pl
values and molecular weights are affected by the depletion and trapping forces differently. The
choice of a fluorescent tracer needs to be determined carefully for each protein antigen.
4. Integration of device with microfluidic cell culture and perform preconcentrated immunoassay
directly from cell secretions. We propose of the use of NIH/3T3 cells and assay for the cytokine
IL-6. IL-6 is secreted from 3T3 fibroblasts at a basal rate but increases when simulated with
certain signaling peptides. (41). In this study, the time course of IL-6 secretion as a function of
stimulation will be tracked.
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